A Clinical Trial Gathering Insight of Patient Reported Factors That Influence Preference Following Once Daily Topical Treatment With LEO 90100 Aerosol Foam and Daivobet Gel in Subjects With Psoriasis Vulgaris
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone-dipropionate/calcipotriol
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Acronyms PSO-INSIGHTFUL
- Sponsors LEO Pharma
- 16 Feb 2017 Last checked against ClinicalTrials.gov record.
- 31 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 30 Jun 2015 Planned End Date changed from 1 May 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.